246 related articles for article (PubMed ID: 29872506)
1. Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer.
Zaytseva YY; Rychahou PG; Le AT; Scott TL; Flight RM; Kim JT; Harris J; Liu J; Wang C; Morris AJ; Sivakumaran TA; Fan T; Moseley H; Gao T; Lee EY; Weiss HL; Heuer TS; Kemble G; Evers M
Oncotarget; 2018 May; 9(37):24787-24800. PubMed ID: 29872506
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression.
Ventura R; Mordec K; Waszczuk J; Wang Z; Lai J; Fridlib M; Buckley D; Kemble G; Heuer TS
EBioMedicine; 2015 Aug; 2(8):808-24. PubMed ID: 26425687
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration.
Zaytseva YY; Harris JW; Mitov MI; Kim JT; Butterfield DA; Lee EY; Weiss HL; Gao T; Evers BM
Oncotarget; 2015 Aug; 6(22):18891-904. PubMed ID: 25970773
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Fatty Acid Synthase Upregulates Expression of CD36 to Sustain Proliferation of Colorectal Cancer Cells.
Drury J; Rychahou PG; He D; Jafari N; Wang C; Lee EY; Weiss HL; Evers BM; Zaytseva YY
Front Oncol; 2020; 10():1185. PubMed ID: 32850342
[TBL] [Abstract][Full Text] [Related]
6. Tissue-Specific Downregulation of Fatty Acid Synthase Suppresses Intestinal Adenoma Formation via Coordinated Reprograming of Transcriptome and Metabolism in the Mouse Model of Apc-Driven Colorectal Cancer.
Drury J; Young LEA; Scott TL; Kelson CO; He D; Liu J; Wu Y; Wang C; Weiss HL; Fan T; Gentry MS; Sun R; Zaytseva YY
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742953
[TBL] [Abstract][Full Text] [Related]
7. Enhanced De Novo Lipid Synthesis Mediated by FASN Induces Chemoresistance in Colorectal Cancer.
Han L; Dai W; Luo W; Ye L; Fang H; Mo S; Li Q; Xu Y; Wang R; Cai G
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765520
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.
Zaytseva YY; Rychahou PG; Gulhati P; Elliott VA; Mustain WC; O'Connor K; Morris AJ; Sunkara M; Weiss HL; Lee EY; Evers BM
Cancer Res; 2012 Mar; 72(6):1504-17. PubMed ID: 22266115
[TBL] [Abstract][Full Text] [Related]
9. FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth.
Wei W; Qin B; Wen W; Zhang B; Luo H; Wang Y; Xu H; Xie X; Liu S; Jiang X; Wang M; Tang Q; Zhang J; Yang R; Fan Z; Lyu H; Lin J; Li K; Lee MH
Signal Transduct Target Ther; 2023 May; 8(1):187. PubMed ID: 37202390
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid synthase enhances colorectal cancer cell proliferation and metastasis via regulating AMPK/mTOR pathway.
Lu T; Sun L; Wang Z; Zhang Y; He Z; Xu C
Onco Targets Ther; 2019; 12():3339-3347. PubMed ID: 31118685
[No Abstract] [Full Text] [Related]
11. Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans.
Li L; Che L; Tharp KM; Park HM; Pilo MG; Cao D; Cigliano A; Latte G; Xu Z; Ribback S; Dombrowski F; Evert M; Gores GJ; Stahl A; Calvisi DF; Chen X
Hepatology; 2016 Jun; 63(6):1900-13. PubMed ID: 26910791
[TBL] [Abstract][Full Text] [Related]
12. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
Ohol YM; Wang Z; Kemble G; Duke G
PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
[TBL] [Abstract][Full Text] [Related]
13.
Jafari N; Drury J; Morris AJ; Onono FO; Stevens PD; Gao T; Liu J; Wang C; Lee EY; Weiss HL; Evers BM; Zaytseva YY
Mol Cancer Res; 2019 Jan; 17(1):140-152. PubMed ID: 30154249
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
Hum Pathol; 2007 Jun; 38(6):842-9. PubMed ID: 17350669
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
Vazquez-Martin A; Colomer R; Brunet J; Menendez JA
Int J Oncol; 2007 Oct; 31(4):769-76. PubMed ID: 17786307
[TBL] [Abstract][Full Text] [Related]
16. Identification of Fasnall as a therapeutically effective Complex I inhibitor.
Mukha D; Dessain J; O'Connor S; Pniewski K; Bertolazzi F; Patel J; Mullins M; Schug ZT
bioRxiv; 2024 May; ():. PubMed ID: 38766222
[TBL] [Abstract][Full Text] [Related]
17. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
[TBL] [Abstract][Full Text] [Related]
18. Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators?
Lupu R; Menendez JA
Endocrinology; 2006 Sep; 147(9):4056-66. PubMed ID: 16809439
[TBL] [Abstract][Full Text] [Related]
19. In silico screening for identification of fatty acid synthase inhibitors and evaluation of their antiproliferative activity using human cancer cell lines.
Nisthul A A; Retnakumari AP; A S; Anto RJ; Sadasivan C
J Recept Signal Transduct Res; 2018 Aug; 38(4):335-341. PubMed ID: 30256698
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers.
Uddin S; Siraj AK; Al-Rasheed M; Ahmed M; Bu R; Myers JN; Al-Nuaim A; Al-Sobhi S; Al-Dayel F; Bavi P; Hussain AR; Al-Kuraya KS
J Clin Endocrinol Metab; 2008 Oct; 93(10):4088-97. PubMed ID: 18682509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
